Terumo’s plasma donation system adopted by Join Parachute to expand access to lifesaving therapies
Ella Day | May 13, 2025 | News story | Biotech/start-up, Sales and Marketing | Haematology, Join Parachute, Pharmacy, Terumo Blood and Cell Technologies (Terumo BCT), biotech, plasma donation
US Biotech company, Terumo Blood and Cell Technologies (Terumo BCT), has announced that Join Parachute will adopt its Rika Plasma Donation System – a platform streamlining plasma collection and improving donor experience. This supports Join Parachute’s efforts to increase plasma donation and access to lifesaving care facilitated by donations. With the blood shortage crisis in the US being a persistent issue, this intervention is particularly pressing.
The Rika Plasma Donation System improves the efficiency of donations. It is equipped to collect up to 1,000ml of plasma and tailors donations based on the height, weight and red blood cells of donors. Moreover, it prioritises a comfortable experience for donors to encourage their return. The system provides an average collection time of less than 35 minutes and allows volunteers to return without being deferred if their initial procedure was not completed.
Both Join Parachute and Terumo BCT share a commitment to expanding access to lifesaving therapies. Terumo BCT’s products support the collection and preparation of blood and cells for the treatment of challenging diseases and conditions. Similarly, Join Parachute increases plasma donations by improving the efficiency of donations and focusing on donor experience.
“Join Parachute is reimagining the future of plasma donation and Rika helps make that vision real,” said Tim Costello, general manager of plasma innovations at Terumo BCT.
CEO of Join Parachute, Joshua Grosbard, added: “The technology [Rika] will help us deliver on our promise to donors while growing access to plasma-based therapies for those who need them most.”
Ella Day
13/5/25
Related Content
Lilly opens fourth US Gateway Labs site
Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, …
LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …
Crown Bioscience opens new US model development centre
Crown Bioscience, a US global contract research organisation (CRO) that is part of JSR Life …
